posted on 2020-06-29, 13:06authored byMicah Dettweiler, Roberta J. Melander, Gina Porras, Caitlin Risener, Lewis Marquez, Tharanga Samarakoon, Christian Melander, Cassandra L. Quave
The rise of antibiotic resistance
presents a significant healthcare challenge and precludes the use
of many otherwise valuable antibiotics. One potential solution to
this problem is the use of antibiotics in combination with resistance-modifying
agents, compounds that act synergistically with existing antibiotics
to resensitize previously resistant bacteria. In this study, 12(S),16ξ-dihydroxycleroda-3,13-dien-15,16-olide, a clerodane
diterpene isolated from the medicinal plant Callicarpa americana, was found to synergize with oxacillin against methicillin-resistant Staphylococcus aureus. This synergy was confirmed by checkerboard
(fractional inhibitory concentration index (FICI) = 0.125) and time-kill
assays, with a subinhibitory dose of 12(S),16ξ-dihydroxycleroda-3,13-dien-15,16-olide
causing the effective concentration of oxacillin to fall below the
susceptibility breakpoint for S. aureus, a >32-fold
decrease in both cases.